|
Slide 015 |
|
 |
Next |
 |
Previous |
 |
Narrative |
 |
Beginning |
 |
End |
 |
Home page |
Rifampicin has a crystalline structure and its manufacturing may negatively influence the pharmacokinetic properties of the drug as shown here where the particle size was changed.